All research
2026-06-02 PubMed

Trichinella spiralis HSP70 Modulates Macrophage Immunity via TLR2/MyD88/ERK, Reducing Muscle Larval Burden by 28% in Mice

Trichinella spiralis HSP70 Mediates Mice Immune Responses via TLR2/MyD88/ERK Signaling Pathway.

Background

Trichinellosis is a significant zoonotic parasitic disease, causing public health concerns and economic losses globally. Current treatments and preventive measures are often insufficient, highlighting the urgent need for effective vaccine candidates. Trichinella spiralis heat shock protein 70 (Ts-HSP70) has emerged as a promising immunomodulatory agent for vaccine development. However, the precise molecular mechanisms by which Ts-HSP70 interacts with host immune cells and orchestrates immune responses, particularly involving key innate immune receptors like Toll-like receptor 2 (TLR2), remain largely undefined.

Study Design

Researchers investigated the immunomodulatory role of recombinant Ts-HSP70 (rTs-HSP70) in vitro using RAW264.7 macrophages. They confirmed the interaction between rTs-HSP70 and mouse TLR2 via co-immunoprecipitation and fluorescence colocalization assays. Macrophages were stimulated with rTs-HSP70 to assess effects on proliferation, phagocytosis, nitric oxide (NO) production, reactive oxygen species (ROS) generation, and cytokine mRNA expression via qPCR. Furthermore, the study explored the activation of NF-κB and MAPK signaling pathways. For in vivo assessment, rTs-HSP70 encapsulated in poly(lactic-co-glycolic acid) (PLGA) nanoparticles was administered to mice to evaluate specific antibody responses and protective efficacy against Trichinella spiralis infection.

Results

In vitro, rTs-HSP70 significantly enhanced RAW264.7 macrophage proliferation and phagocytic activity. It also markedly increased NO and ROS production, key indicators of macrophage activation. Gene expression analysis revealed that rTs-HSP70 upregulated the mRNA levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, alongside the anti-inflammatory cytokine IL-10. These findings suggest a broad activation of macrophage immune functions. Furthermore, the study demonstrated that rTs-HSP70 induced the activation of both NF-κB and MAPK signaling pathways, crucial for immune gene expression. Functional inhibition assays specifically indicated that ERK activation, a component of the MAPK pathway, was partially dependent on the TLR2/MyD88 signaling axis. This establishes a direct mechanistic link. > In the in vivo mouse model, rTs-HSP70 encapsulated in PLGA nanoparticles elicited robust specific antibody responses and conferred partial protection, resulting in a 28.0% reduction in muscle larval burden.

Key Findings

  • rTs-HSP70 significantly enhanced RAW264.7 macrophage proliferation and phagocytic activity.
  • rTs-HSP70 increased NO and ROS production in macrophages, indicating activation.
  • rTs-HSP70 upregulated mRNA expression of IL-1β, IL-6, TNF-α, and IL-10 in macrophages.
  • rTs-HSP70 activated NF-κB and MAPK signaling pathways, with ERK activation partially dependent on TLR2/MyD88.
  • rTs-HSP70 in PLGA nanoparticles reduced muscle larval burden by 28.0% in mice.

Why It Matters

This research provides critical insights into the immunomodulatory mechanisms of Trichinella spiralis HSP70, specifically its interaction with the host immune system via the TLR2/MyD88/ERK pathway. Understanding this pathway is crucial for developing novel vaccine strategies against trichinellosis. The demonstrated 28.0% reduction in larval burden in mice suggests that Ts-HSP70, particularly when delivered via nanoparticles, holds significant promise as a vaccine candidate. This mechanistic clarity could inform the design of more effective immunotherapies or adjuvants, potentially leading to protocols that enhance host defense against parasitic infections. While preclinical, these findings lay the groundwork for future translational studies aimed at protecting both human and animal populations from this debilitating zoonosis.


trichinella-spiralis hsp70 immunomodulation tLlr2 myd88 erk
Source: pubmed:42222277 · Ingested 2026-06-02 · Digest: gemini-2.5-flash